Morgan Stanley lists biotechs with detrimental business benefit, 2022 catalysts (NASDAQ:GLPG)
ipopba/iStock via Getty Pictures Reviewing its coverage on biotechs with adverse organization values, Morgan Stanley says that the amount of companies on the list with...